Alterity Therapeutics (ATHE) Enterprise Value Growth (1y) (2010 - 2025)
Alterity Therapeutics (ATHE) Enterprise Value Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -988.88% |
| Jun 30, 2025 | -13,779.93% |
| Dec 31, 2024 | 71.11% |
| Jun 30, 2024 | 16.89% |
| Dec 31, 2023 | 55.10% |
| Jun 30, 2023 | 99.26% |
| Dec 31, 2022 | 15.16% |
| Jun 30, 2022 | -15.19% |
| Dec 31, 2021 | -5.24% |
| Jun 30, 2021 | -259.18% |
| Dec 31, 2020 | -207.84% |
| Jun 30, 2020 | 40.24% |
| Dec 31, 2019 | 23.88% |
| Jun 30, 2019 | 12.55% |
| Dec 31, 2018 | 35.08% |
| Jun 30, 2018 | 30.32% |
| Dec 31, 2017 | 21.51% |
| Jun 30, 2017 | 22.47% |
| Dec 31, 2016 | 14.63% |
| Jun 30, 2016 | 21.33% |